Sign in
Join
Click here - to use the wp menu builder
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Create an account
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Search
Type here...
Search
Home
Trending
Analysis
Research Reports
Contact Us
My account
Get into your account.
Login
Register
Search
My account
Get into your account.
Login
Register
Log In
Profile
Log Out
type here...
Search
Facebook
Instagram
Twitter
Youtube
Log In
Profile
Log Out
type here...
Search
Facebook
Instagram
Twitter
Youtube
Home
Trending
Analysis
Research Reports
Contact Us
Search
START FREE TRIAL
My account
Get into your account.
Login
Register
Home
Trending
Analysis
Research Reports
Contact Us
Search
START FREE TRIAL
My account
Get into your account.
Login
Register
Technology & AI
Is Nvidia Building Demand—Or Just Buying It?
Technology & AI
Ishan Majumdar
-
January 27, 2026
Nvidia (NASDAQ:NVDA) isn’t just selling chips anymore—it’s quietly building the physical and digital...
Is The NVIDIA AI Hype OVER? OpenAI’s Cash Burn Sparks New Investor Doubts!
Technology & AI
Ishan Majumdar
-
January 21, 2026
Is The Nvidia AI Hype Over? That question took center stage this week...
OpenAI vs Google Gemini: Will Gemini Keep Up with ChatGPT’s OS Ambitions?
Technology & AI
Ishan Majumdar
-
January 20, 2026
OpenAI is no longer building “just” an AI assistant. Over the past year,...
Load more
M&A
Ascendis Pharma Becomes M&A Target Again—European Suitors In Play?
M&A
Ishan Majumdar
-
January 26, 2026
Ascendis Pharma (NASDAQ:ASND) has suddenly become one of the hottest tickers in biotech...
BioMarin Amicus Acquisition: A $4.8 Billion Bet on Rare Disease Domination
Healthcare
Ishan Majumdar
-
December 20, 2025
BioMarin Pharmaceutical (NASDAQ:BMRN) just made its boldest move in years—unveiling a $4.8 billion...
APi Group CertaSite Acquisition Sparks Investor Debate
Industrials
Ishan Majumdar
-
December 11, 2025
In a season crowded with earnings calls, margin debates, and cautious optimism, one...
Load more
Consumer & Retail
Nike Shuts RTFKT Unit & Signals End of Web3 Ambitions—The Core Sports Strategy Takes Over!
Consumer & Retail
Ishan Majumdar
-
January 8, 2026
Nike (NYSE:NKE) has officially closed the book on its experiment with digital collectibles....
Target Activist Investor Stake: What a $5B Catalyst Means for Stores, Labor & Margins
Consumer & Retail
Ishan Majumdar
-
December 31, 2025
Target (NYSE:TGT) had a bruising 2025. Sales slid for the second straight year,...
Coca-Cola New CEO 2026 Battles A Major Sugar Backlash!
Consumer & Retail
Ishan Majumdar
-
December 12, 2025
In a major leadership transition that could define the future of Coca-Cola (NYSE:KO),...
Load more
Premium
Is Nvidia Building Demand—Or Just Buying It?
Technology & AI
Ishan Majumdar
-
January 27, 2026
Nvidia (NASDAQ:NVDA) isn’t just selling chips anymore—it’s quietly building the physical and digital...
Gold & Silver Are Rallying — But The REAL Signal Is The Split!
Miscellaneous
Ishan M.
-
January 27, 2026
Gold has pushed decisively above the psychological threshold that dominated market chatter, while...
Ascendis Pharma Becomes M&A Target Again—European Suitors In Play?
M&A
Ishan Majumdar
-
January 26, 2026
Ascendis Pharma (NASDAQ:ASND) has suddenly become one of the hottest tickers in biotech...
Load more
Healthcare
Ascendis Pharma Becomes M&A Target Again—European Suitors In Play?
M&A
Ishan Majumdar
-
January 26, 2026
Ascendis Pharma (NASDAQ:ASND) has suddenly become one of the hottest tickers in biotech...
Boston Scientific Penumbra Acquisition: The $15 Billion Gamble That Could Dominate Neurovascular Markets
Healthcare
Ishan Majumdar
-
January 16, 2026
If you're wondering what Boston Scientific (NYSE:BSX) has been up to lately, buckle...
AbbVie Trump Investment Deal: How Medicaid Cuts Bought Regulatory Peace!
Healthcare
Ishan Majumdar
-
January 13, 2026
AbbVie (NYSE:ABBV) just made a bold move—and the stakes are massive. The company...
Load more
Energy
Chevron Trump Venezuela Strategy in Crisis: Why Chevron Is Slamming the Brakes
Energy
Ishan Majumdar
-
January 20, 2026
It’s a standoff that pits shareholder caution against political ambition—and Chevron (NYSE:CVX) is...
BP Low-Carbon Write-Down Signals a $5B Strategy Reset
Energy
Ishan Majumdar
-
January 15, 2026
BP (NYSE:BP) just dropped a bombshell for Q4 2025—and the markets are still...
Chevron Venezuela Oil Investment: Trump’s Secret Weapon Against Maduro?
Energy
Ishan Majumdar
-
December 23, 2025
Chevron’s (NYSE:CVX) century-long presence in Venezuela is turning into a high-stakes test of...
Load more
Industrials
Howmet Buys CAM: The $1.8 Billion Bet That Could Reshape Aerospace
Industrials
Ishan Majumdar
-
December 23, 2025
On December 22, 2025, Howmet Aerospace (NYSE:HWM) announced plans to acquire Consolidated Aerospace...
APi Group CertaSite Acquisition Sparks Investor Debate
Industrials
Ishan Majumdar
-
December 11, 2025
In a season crowded with earnings calls, margin debates, and cautious optimism, one...
ZIM Stock Surges As Board Seeks Buyers — Is A Buyout Imminent?
Industrials
Ishan Majumdar
-
September 25, 2025
ZIM Integrated Shipping Services saw its stock jump 6.6% after reports surfaced that...
Load more
Miscellaneous
Gold & Silver Are Rallying — But The REAL Signal Is The Split!
Miscellaneous
Ishan M.
-
January 27, 2026
Gold has pushed decisively above the psychological threshold that dominated market chatter, while...
Barington Pushes Bill Holdings Sale—Who’s Buying?
Miscellaneous
Ishan Majumdar
-
December 5, 2025
Bill Holdings just got another uninvited guest at the table—and this one is...
COP30 Impact on US Stocks: The 4 Quiet Tickers No One Is Watching (But Should Be)
Miscellaneous
Ishan Majumdar
-
November 24, 2025
The latest update from COP30 has added fresh momentum to global climate negotiations,...
Load more
Trending
Ascendis Pharma Becomes M&A Target Again—European Suitors In Play?
M&A
Ishan Majumdar
-
January 26, 2026
Ascendis Pharma (NASDAQ:ASND) has suddenly become one of the hottest tickers in biotech...
PayPal Buys Cymbio—What It Really Means For The Future Of AI Shopping
Finance
Ishan Majumdar
-
January 23, 2026
PayPal is acquiring Cymbio, a Tel Aviv-based platform that helps brands sell across...
Netflix Just Missed Earnings—But That’s NOT The WORST News!
Media & Entertainment
Ishan Majumdar
-
January 22, 2026
Netflix (NASDAQ:NFLX) rarely delivers a quiet earnings report, but this one landed with...
Load more
Technology & AI
Is Nvidia Building Demand—Or Just Buying It?
Technology & AI
Ishan Majumdar
-
January 27, 2026
Nvidia (NASDAQ:NVDA) isn’t just selling chips anymore—it’s quietly building the physical and digital...
Is The NVIDIA AI Hype OVER? OpenAI’s Cash Burn Sparks New Investor Doubts!
Technology & AI
Ishan Majumdar
-
January 21, 2026
Is The Nvidia AI Hype Over? That question took center stage this week...
OpenAI vs Google Gemini: Will Gemini Keep Up with ChatGPT’s OS Ambitions?
Technology & AI
Ishan Majumdar
-
January 20, 2026
OpenAI is no longer building “just” an AI assistant. Over the past year,...
Load more
Technology & AI
Is Nvidia Building Demand—Or Just Buying It?
Technology & AI
Ishan Majumdar
-
January 27, 2026
Nvidia (NASDAQ:NVDA) isn’t just selling chips anymore—it’s quietly building the physical and digital...
Is The NVIDIA AI Hype OVER? OpenAI’s Cash Burn Sparks New Investor Doubts!
Technology & AI
Ishan Majumdar
-
January 21, 2026
Is The Nvidia AI Hype Over? That question took center stage this week...
OpenAI vs Google Gemini: Will Gemini Keep Up with ChatGPT’s OS Ambitions?
Technology & AI
Ishan Majumdar
-
January 20, 2026
OpenAI is no longer building “just” an AI assistant. Over the past year,...
Load more
Technology & AI
Is Nvidia Building Demand—Or Just Buying It?
Technology & AI
Ishan Majumdar
-
January 27, 2026
Nvidia (NASDAQ:NVDA) isn’t just selling chips anymore—it’s quietly building the physical and digital...
Is The NVIDIA AI Hype OVER? OpenAI’s Cash Burn Sparks New Investor Doubts!
Technology & AI
Ishan Majumdar
-
January 21, 2026
Is The Nvidia AI Hype Over? That question took center stage this week...
OpenAI vs Google Gemini: Will Gemini Keep Up with ChatGPT’s OS Ambitions?
Technology & AI
Ishan Majumdar
-
January 20, 2026
OpenAI is no longer building “just” an AI assistant. Over the past year,...
Load more
M&A
Ascendis Pharma Becomes M&A Target Again—European Suitors In Play?
M&A
Ishan Majumdar
-
January 26, 2026
Ascendis Pharma (NASDAQ:ASND) has suddenly become one of the hottest tickers in biotech...
BioMarin Amicus Acquisition: A $4.8 Billion Bet on Rare Disease Domination
Healthcare
Ishan Majumdar
-
December 20, 2025
BioMarin Pharmaceutical (NASDAQ:BMRN) just made its boldest move in years—unveiling a $4.8 billion...
APi Group CertaSite Acquisition Sparks Investor Debate
Industrials
Ishan Majumdar
-
December 11, 2025
In a season crowded with earnings calls, margin debates, and cautious optimism, one...
Load more
Consumer & Retail
Is Nvidia Building Demand—Or Just Buying It?
Technology & AI
Ishan Majumdar
-
January 27, 2026
Nvidia (NASDAQ:NVDA) isn’t just selling chips anymore—it’s quietly building the physical and digital...
Gold & Silver Are Rallying — But The REAL Signal Is The Split!
Miscellaneous
Ishan M.
-
January 27, 2026
Gold has pushed decisively above the psychological threshold that dominated market chatter, while...
Ascendis Pharma Becomes M&A Target Again—European Suitors In Play?
M&A
Ishan Majumdar
-
January 26, 2026
Ascendis Pharma (NASDAQ:ASND) has suddenly become one of the hottest tickers in biotech...
Load more
Premium
Is Nvidia Building Demand—Or Just Buying It?
Technology & AI
Ishan Majumdar
-
January 27, 2026
Nvidia (NASDAQ:NVDA) isn’t just selling chips anymore—it’s quietly building the physical and digital...
Gold & Silver Are Rallying — But The REAL Signal Is The Split!
Miscellaneous
Ishan M.
-
January 27, 2026
Gold has pushed decisively above the psychological threshold that dominated market chatter, while...
Ascendis Pharma Becomes M&A Target Again—European Suitors In Play?
M&A
Ishan Majumdar
-
January 26, 2026
Ascendis Pharma (NASDAQ:ASND) has suddenly become one of the hottest tickers in biotech...
Load more
Healthcare
Ascendis Pharma Becomes M&A Target Again—European Suitors In Play?
M&A
Ishan Majumdar
-
January 26, 2026
Ascendis Pharma (NASDAQ:ASND) has suddenly become one of the hottest tickers in biotech...
Boston Scientific Penumbra Acquisition: The $15 Billion Gamble That Could Dominate Neurovascular Markets
Healthcare
Ishan Majumdar
-
January 16, 2026
If you're wondering what Boston Scientific (NYSE:BSX) has been up to lately, buckle...
AbbVie Trump Investment Deal: How Medicaid Cuts Bought Regulatory Peace!
Healthcare
Ishan Majumdar
-
January 13, 2026
AbbVie (NYSE:ABBV) just made a bold move—and the stakes are massive. The company...
Load more
Energy
Chevron Trump Venezuela Strategy in Crisis: Why Chevron Is Slamming the Brakes
Energy
Ishan Majumdar
-
January 20, 2026
It’s a standoff that pits shareholder caution against political ambition—and Chevron (NYSE:CVX) is...
BP Low-Carbon Write-Down Signals a $5B Strategy Reset
Energy
Ishan Majumdar
-
January 15, 2026
BP (NYSE:BP) just dropped a bombshell for Q4 2025—and the markets are still...
Chevron Venezuela Oil Investment: Trump’s Secret Weapon Against Maduro?
Energy
Ishan Majumdar
-
December 23, 2025
Chevron’s (NYSE:CVX) century-long presence in Venezuela is turning into a high-stakes test of...
Load more
Industrials
Howmet Buys CAM: The $1.8 Billion Bet That Could Reshape Aerospace
Industrials
Ishan Majumdar
-
December 23, 2025
On December 22, 2025, Howmet Aerospace (NYSE:HWM) announced plans to acquire Consolidated Aerospace...
APi Group CertaSite Acquisition Sparks Investor Debate
Industrials
Ishan Majumdar
-
December 11, 2025
In a season crowded with earnings calls, margin debates, and cautious optimism, one...
ZIM Stock Surges As Board Seeks Buyers — Is A Buyout Imminent?
Industrials
Ishan Majumdar
-
September 25, 2025
ZIM Integrated Shipping Services saw its stock jump 6.6% after reports surfaced that...
Load more
Miscellaneous
Gold & Silver Are Rallying — But The REAL Signal Is The Split!
Miscellaneous
Ishan M.
-
January 27, 2026
Gold has pushed decisively above the psychological threshold that dominated market chatter, while...
Barington Pushes Bill Holdings Sale—Who’s Buying?
Miscellaneous
Ishan Majumdar
-
December 5, 2025
Bill Holdings just got another uninvited guest at the table—and this one is...
COP30 Impact on US Stocks: The 4 Quiet Tickers No One Is Watching (But Should Be)
Miscellaneous
Ishan Majumdar
-
November 24, 2025
The latest update from COP30 has added fresh momentum to global climate negotiations,...
Load more